查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1831933

犬异位性皮肤炎市场报告（按药物类别、给药途径、配销通路和地区划分）2025-2033

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球犬异位性皮肤炎市场规模达 24 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 77 亿美元，2025-2033 年期间的成长率 (CAGR) 为 13.1%。

犬异位性皮肤炎 (CAD) 是一种由花粉、屋尘、昆虫叮咬、草和食物成分等过敏原引起的犬类过敏性皮肤病。它是一种遗传性疾病，通常影响六个月至三岁的犬隻。它通常会影响动物的腹部、口腔、眼睛、趾间皮肤、耳廓、腕骨、肘部和会阴区域。 CAD 的特征是各种症状，例如过度抓痒、爪子、腋窝和脸部周围发炎和搔痒。此病可以透过免疫抑制剂、单株抗体和糖皮质激素治疗。这些药物可以透过口服、注射和外用药物给药。已知它在德国牧羊犬、拉布拉多犬、黄金猎犬和哈巴狗中非常普遍。

犬异位性皮肤炎市场趋势：

在全球范围内，家养犬冠状动脉疾病（CAD）发生率的上升是市场前景乐观的关键因素之一。这可以归因于不断变化的环境条件、日益严重的空气污染以及长期接触过敏原。此外，宠物主人对CAD早期症状和体征（例如发红、皮肤油腻和酵母味）的担忧和认识日益加深，也推动了市场的成长。此外，单株抗体在治疗CAD方面的广泛应用也有利于市场的成长。这些抗体有助于引导所需的免疫反应，并抑制疾病的传播。同时，致力于提供更优质动物照护的兽医、医院和诊所数量不断增加，也对市场成长产生了正面的影响。其他因素，包括政府推出的各项措施，限制在动物身上使用非处方人类药物，以及兽医领域的广泛研发，预计将推动市场的成长。

本报告回答的关键问题：

  • 到目前为止，全球犬异位性皮肤炎市场表现如何，未来几年又会如何表现？
  • COVID-19 对全球犬异位性皮肤炎市场有何影响？
  • 主要的区域市场有哪些？
  • 根据药物类别，市场是如何分類的？
  • 根据行政路径，市场如何划分？
  • 根据配销通路，市场是如何分類的？
  • 该产业的价值链分为哪些阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球犬异位性皮肤炎市场的结构是怎么样的？主要参与者是谁？
  • 产业竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球犬异位性皮肤炎市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依药品类别

  • 糖皮质激素
  • 免疫抑制剂
  • 单株抗体
  • 其他的

第七章：市场区隔：依行政途径

  • 外用
  • 口服
  • 注射剂

第八章：市场区隔：按配销通路

  • 兽医院
  • 宠物诊所
  • 药局和药局
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AB Science
    • Bimeda Inc.
    • Bioceltix SA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Phibro Animal Health Corporation
    • Toray Industries Inc.
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
Product Code: SR112025A4700

The global canine atopic dermatitis market size reached USD 2.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 13.1% during 2025-2033.

Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.

Canine Atopic Dermatitis Market Trends:

The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Drug Class Type:

  • Glucocorticoids
  • Immunosuppressants
  • Monoclonal Antibody
  • Others

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Pet Clinics
  • Pharmacies and Drugstores
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global canine atopic dermatitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global canine atopic dermatitis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Canine Atopic Dermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class Type

  • 6.1 Glucocorticoids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Monoclonal Antibody
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Injectable
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pet Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Pharmacies and Drugstores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AB Science
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Bimeda Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bioceltix SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Ceva Sante Animale
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Dechra Pharmaceuticals PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Elanco Animal Health Incorporated
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Phibro Animal Health Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Toray Industries Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vetoquinol S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2024
  • Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
  • Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
  • Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million USD), 2025-2033
  • Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
  • Table 7: Global: Canine Atopic Dermatitis Market: Key Players